OpenAI CEO Sam Altman’s new brain-computer interface startup, Merge Labs, is being spun out of the Los Angeles–based nonprofit Forest Neurotech, according to a source with direct knowledge of the ...
After achieving early breakthroughs in materials development, in vitro nanoparticle stimulation and signal reading, Subsense secures additional $10 million to accelerate product development and ...
Subsense, Inc., a developer of non-surgical invasive, nanoparticle-based brain-computer interfaces (BCIs), has added $10 million in new capital following positive early breakthroughs, bringing total ...
Could a future exist where the brain and artificial intelligence systems communicate as effortlessly as a smartphone connecting to Wi-Fi? This may sound like science fiction, but researchers are ...
Scientists working to enhance brain-computer interface (BCI) technology—which allows people to control devices with their thoughts—have found they can improve the performance of electrodes implanted ...
O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her ...
Every four years at the Cybathlon, teams of researchers and technology “pilots” compete to see whose brain-computer interface holds the most promise. Owen Collumb, a Cybathlon race pilot who has been ...
Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish company’s graphene-based brain-computer interface (BCI) technology. Inbrain ...
Barcelona-based INBRAIN Neuroelectronics, which offers a graphene-based brain-computer interface (BCI) therapeutics platform, announced a strategic partnership with tech giant Microsoft to advance the ...
Apple @ Work is exclusively brought to you by Mosyle, the only Apple Unified Platform. Mosyle is the only solution that integrates in a single professional grade platform all the solutions necessary ...
Synchron has reeled in another $200 million in a series D round—cash the company said it will use to expand operations and accelerate commercialization of its nonsurgical brain-computer interface (BCI ...